NCT07445542Completed
Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia
A Multi-center, Open-label, Observational Study to Evaluate the Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
A Multi-center, Open-label, Observational Study to evaluate the Efficacy and Safety of Pitavastatin/Ezetimibe after switching from Statin Monotherapy to Pitavastatin/Ezetimibe in patients with Hypercholesterolemia
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 6927 (actual)
- First submitted
- 25 Feb 2026
- Start date
- 18 Dec 2021
- Primary completion date
- 13 May 2025
- Lead sponsor
- JW Pharmaceutical
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT07445542
What you commit to
- Study type: Observational
- Participants enrolled: 6927
- From 18 Dec 2021 to the primary completion date, 13 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of other lipid-lowering therapies within 4 weeks before screening.
Lab values
- History of clinically significant laboratory abnormalities within 1 year.
Other
- Participation in other clinical trials within 4 weeks.
- Contraindications to Pitavastatin/Ezetimibe
Who the study is looking for
- Adults (≥19 years) with hypercholesterolemia.
- On a stable dose of statin monotherapy for at least 8 weeks.
- Scheduled to switch to Pitavastatin/Ezetimibe per investigator's decision.
- Provided voluntary written informed consent.
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul Metropolitan Government Seoul National University Boramae Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.